Households exposed to COVID-19 now have an oral drug specifically cleared to prevent infection after contact with a sick ...

A new oral medication called Xocova has become the first FDA-approved post-exposure COVID pill, cutting infection risk by 67 ...

An experimental oral medication can dramatically lower the risk of getting COVID-19 after an exposure. The new pill, Ensitrelvir, is already approved for use in Japan. Infectious disease experts are ...

You have limited options right now if you know you’ve been exposed to COVID-19. There used to be monoclonal antibody treatments available, but those were given through an IV, and the Food and Drug ...

A new COVID-19 pill is hitting the market. It's different from past coronavirus medications and antivirals, and it has the potential to be an absolute game-changer. The U.S. Food and Drug ...

Ensitrelvir has already been approved as a prophylactic in Japan, with an FDA decision in the U.S. expected soon. Reading time 3 minutes A drug already approved to treat covid-19 in some countries is ...

A new report estimates speeding up FDA drug approvals by one year could generate over $10 trillion in economic value from ...

Merck is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available ...

CLEVELAND — Researchers at the University of Cincinnati and the Icahn School of Medicine at Mount Sinai have identified two weather patterns most likely to trigger headaches: an approaching cold front ...